PREVALENCE AND RESPONSE OF BLEEDING, INCLUDING TRANSFUSION DEPENDENT BLEEDING, TO INTERVENTION IN HYPERTROPHIC CARDIOMYOPATHY  by Waldo, Oral et al.
Heart Failure and Cardiomyopathies
A847
JACC April 1, 2014
Volume 63, Issue 12
prevalence and reSponSe of bleeding, including tranSfuSion dependent bleeding, to 
intervention in hypertrophic cardioMyopathy
Poster Contributions
Hall C
Saturday, March 29, 2014, 3:45 p.m.-4:30 p.m.
Session Title: Heart Failure and Cardiomyopathies: Diagnostic, Prognostic and Therapeutic Strategies in Cardiomyopathies
Abstract Category: 12. Heart Failure and Cardiomyopathies: Clinical
Presentation Number: 1147-201
Authors: Oral Waldo, Pragnesh Parikh, Joseph Vander Linde, Joseph Blackshear, Mayo Clinic, Jacksonville, FL, USA
background: Loss of high molecular weight multimers (HMWM) of von Willebrand factor (VWF) and clinically significant bleeding have been 
described in hypertrophic obstructive cardiomyopathy (HOCM). However, there are no data describing the prevalence of bleeding and only case 
reports describing the effects of intervention.
Methods and results: From 2010 to 2013, in a tertiary referral center which includes advanced gastrointestinal endoscopy including double 
balloon enteroscopy, we prospectively recorded bleeding histories in 89 patients with HOCM. Twenty-five patients had a history of recent bleeding, 
and their peak instantaneous left ventricular outflow gradient (median, IQR) was 55 (42-68) mm Hg. Their VWF antigen levels were normal, 
154±70%, but 22 / 25 patients manifested loss of high molecular weight multimers of VWF on gel electrophoresis. The three patients with normal 
multimers had latent obstruction. Gastrointestinal endoscopy, gradient reducing medical therapy, or surgical/catheter-based septal reduction 
therapies were made based on the severity of symptoms. Eleven of the patients described episodes of transfusion dependent gastrointestinal 
bleeding. In these, arteriovenous malformations were identified in 7, and no lesion responsible for bleeding in 4. In 6 patients a remission of 
bleeding was achieved for 2-14 months with medical therapy alone, but bleeding recurred in all. Seven patients who underwent septal reduction 
therapy have been free of bleeding for 11 (9-17) months. Four patients declined septal reduction therapy and continued to require transfusions 
despite medical treatment of HOCM. Fourteen patients were not transfusion dependent but gave histories of acquired bleeding (recurrent melena/
hematochezia n=8, recurrent epistaxis n=5, recurrent peri-procedural bleeding n=1). Medical therapy (n=6), septal myectomy (n=6) and septal 
ablation (n=2) were associated with no recurrent bleeding in these 14 patients over 17 (4-26) months.
conclusion: Spontaneous bleeding as a manifestation of pressure gradient-induced acquired von Willebrand syndrome is frequent in HOCM. 
Severe bleeding appears to respond to gradient reduction therapy.
